Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01314352 · ClinicalTrials.gov registry record · Phase 1
Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions
A Phase 1 study of Fed, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT01314352 is a Phase 1 study of Fed that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01314352, a Phase 1 study of Fed, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the rate and extent of absorption of Dr. Reddy's Desloratadine 5 mg tablet to that of Clarinex® 5 mg tablet in healthy subjects under fed conditions.
Conditions Studied
Interventions
- DRUG Desloratadine
Study Locations (1)
Florida
- SFBC, Ft. Myers, Inc., - Fort Myers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2005-12 |
| Est. Completion | 2006-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01314352
The ClinicalTrials.gov registry entry for NCT01314352 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fed appearing as the primary indexed condition, and to 1 intervention - of which Desloratadine is the first listed.
NCT01314352 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01314352 about?
NCT01314352 is a clinical study titled "Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions". The purpose of this study is to compare the rate and extent of absorption of Dr. Reddy's Desloratadine 5 mg tablet to that of Clarinex® 5 mg tablet in healthy subjects under fed conditions.
What is the current status of trial NCT01314352?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2005-12. Estimated completion is 2006-03.
What conditions does trial NCT01314352 study?
This clinical trial studies the following conditions: Fed.
What interventions are being tested in trial NCT01314352?
The interventions under investigation include: Desloratadine (DRUG).
Who is sponsoring clinical trial NCT01314352?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01314352 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.